NCT06059261 2026-02-18Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.Chongqing University Cancer HospitalPhase 2 Recruiting30 enrolled
NCT06455410 2024-06-25GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal CarcinomaSun Yat-sen UniversityPhase 2 Recruiting216 enrolled